1. From the ICOS Corporation, Bothell, WA; the Department of Pediatrics and the Department of Pathology, Washington University School of Medicine, Saint Louis, MO; Lymphocyte Signaling and Development, Molecular Immunology Programme, The Babraham Institute, Cambridge, United Kingdom; and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.